April 01, 1997; 48 (4 Suppl 4) Articles
Clinical evaluation of ALS drugs
Benjamin Rix Brooks
First published April 1, 1997, DOI: https://doi.org/10.1212/WNL.48.4_Suppl_4.23S
Benjamin Rix Brooks
MD
Clinical evaluation of ALS drugs
Benjamin Rix Brooks
Neurology Apr 1997, 48 (4 Suppl 4) 23S-27S; DOI: 10.1212/WNL.48.4_Suppl_4.23S
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 48 no. 4 Suppl 4 23S-27S
Print ISSN:
Online ISSN:
History:
- First Published April 1, 1997.
Copyright & Usage:
Copyright 1997 by Advanstar Communications Inc.
Author Disclosures
- Benjamin Rix Brooks, MD
- Benjamin Rix Brooks, MD
- From the University of Wisconsin ALS Clinical Research Center, Neurology Service, William S. Middleton Memorial VA Medical Center, Great Lakes Veterans Integrated Service Network, Madison, WI.
- Address correspondence and reprint requests to Dr Brooks, Director, ALS Clinic and ALS Clinical Research Center, University of Wisconsin Hospital and Clinics, Department of Neurology, 600 Highland Ave., Madison, WI 53792.
Article usage
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Dr. Ann Yeh and Dr. Daniela Castillo Villagrán
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Articles
New approaches to the treatment of ALSRobert G. Miller, Robert Sufit et al.Neurology, April 01, 1997 -
Articles
Multipoint incremental motor unit number estimation as an outcome measure in ALSJ.M. Shefner, M.L. Watson, L. Simionescu et al.Neurology, June 15, 2011 -
Brief Communications
Relationship of the Tufts Quantitative Neuromuscular Exam (TQNE) and the Sickness Impact Profile (SIP) in measuring progression of ALSD. McGuire, L. Garrison, C. Armon et al.Neurology, May 01, 1996 -
Introduction
ALS standard of care consensus conferenceRobert G. Miller et al.Neurology, April 01, 1997